Am J Perinatol 2019; 36(06): 574-580
DOI: 10.1055/s-0038-1668549
Original Article
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Implementing Obstetric Venous Thromboembolism Protocols on a Statewide Basis: Results from New York State's Safe Motherhood Initiative

Alexander M. Friedman
1   Department of Obstetrics and Gynecology, College of Physicians and Surgeons, Columbia University, New York
,
Cande V. Ananth
1   Department of Obstetrics and Gynecology, College of Physicians and Surgeons, Columbia University, New York
2   Department of Epidemiology, Mailman School of Public Health, Columbia University, New York
,
Jessica A. Lavery
1   Department of Obstetrics and Gynecology, College of Physicians and Surgeons, Columbia University, New York
,
Adiel A. Fleischer
3   Department of Obstetrics and Gynecology, North Shore University Hospital, Manhasset, New York
,
Cynthia Chazotte
4   Department of Obstetrics and Gynecology, Albert Einstein College of Medicine, New York, New York
,
Mary E. D'Alton
1   Department of Obstetrics and Gynecology, College of Physicians and Surgeons, Columbia University, New York
,
for the Safe Motherhood Initiative Venous Thromboembolism Work Group
› Author Affiliations
Funding The Safe Motherhood Initiative was supported by a grant from Merck for Mothers.
Further Information

Publication History

16 April 2018

01 July 2018

Publication Date:
13 September 2018 (online)

Abstract

Objective To determine whether a state-level initiative to reduce obstetric venous thromboembolism (VTE) risk affected outcomes and process measures.

Methods In 2013, the Safe Motherhood Initiative (SMI) developed a VTE safety bundle to reduce obstetric VTE risk. A total of 117 of 124 hospitals providing obstetrical services in New York participated in SMI. Data evaluating thromboembolism events (deep vein thrombosis and pulmonary embolism) and thromboprophylaxis process measures were collected from March through November 2015.

Results A total of 107 hospitals, in any individual quarter, reported data on each of the VTE bundle outcomes and measures. Centers that provided low-risk care (Level 1 centers) reported the lowest rate of bundle implementation at the end of the study period (55.6%). Mechanical prophylaxis for a cesarean was common at all centers. Hospitals that adopted the bundle were more likely to provide routine pharmacologic prophylaxis for women undergoing cesarean. The risk of VTE did not differ by bundle implementation.

Conclusion While adoption of the SMI VTE bundle occurred at a majority of centers across New York, uptake was less likely at low-acuity centers. Bundle adoption was associated with implementation of recommended practices. The rare nature of VTE events underscores the need for large data samples to determine the best prophylaxis strategies.

 
  • References

  • 1 Clark SL, Belfort MA, Dildy GA, Herbst MA, Meyers JA, Hankins GD. Maternal death in the 21st century: causes, prevention, and relationship to cesarean delivery. Am J Obstet Gynecol 2008; 199 (01) 36.e1-36.e5
  • 2 Clark SL, Christmas JT, Frye DR, Meyers JA, Perlin JB. Maternal mortality in the United States: predictability and the impact of protocols on fatal postcesarean pulmonary embolism and hypertension-related intracranial hemorrhage. Am J Obstet Gynecol 2014; 211 (01) 32.e1-32.e9
  • 3 Bates SM, Greer IA, Middeldorp S, Veenstra DL, Prabulos AM, Vandvik PO. VTE, thrombophilia, antithrombotic therapy, and pregnancy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2012; 141 (2, Suppl): e691S-e736S
  • 4 DʼAlton ME, Friedman AM, Smiley RM. , et al. National Partnership for Maternal Safety: Consensus Bundle on Venous Thromboembolism. Obstet Gynecol 2016; 128 (04) 688-698
  • 5 Creanga AA, Berg CJ, Syverson C, Seed K, Bruce FC, Callaghan WM. Pregnancy-related mortality in the United States, 2006-2010. Obstet Gynecol 2015; 125 (01) 5-12
  • 6 Callaghan WM, Creanga AA, Kuklina EV. Severe maternal morbidity among delivery and postpartum hospitalizations in the United States. Obstet Gynecol 2012; 120 (05) 1029-1036
  • 7 Ghaji N, Boulet SL, Tepper N, Hooper WC. Trends in venous thromboembolism among pregnancy-related hospitalizations, United States, 1994-2009. Am J Obstet Gynecol 2013; 209 (05) 433.e1-433.e8
  • 8 Jacobsen AF, Skjeldestad FE, Sandset PM. Incidence and risk patterns of venous thromboembolism in pregnancy and puerperium--a register-based case-control study. Am J Obstet Gynecol 2008; 198 (02) 233.e1-233.e7
  • 9 James AH, Jamison MG, Brancazio LR, Myers ER. Venous thromboembolism during pregnancy and the postpartum period: incidence, risk factors, and mortality. Am J Obstet Gynecol 2006; 194 (05) 1311-1315
  • 10 Sultan AA, Tata LJ, West J. , et al. Risk factors for first venous thromboembolism around pregnancy: a population-based cohort study from the United Kingdom. Blood 2013; 121 (19) 3953-3961
  • 11 James A. ; Committee on Practice Bulletins—Obstetrics. Practice bulletin no. 123: thromboembolism in pregnancy. Obstet Gynecol 2011; 118 (03) 718-729
  • 12 Gould MK, Garcia DA, Wren SM. , et al. Prevention of VTE in nonorthopedic surgical patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2012; 141 (2, Suppl): e227S-e277S
  • 13 Kahn SR, Lim W, Dunn AS. , et al. Prevention of VTE in nonsurgical patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2012; 141 (2, Suppl): e195S-e226S
  • 14 The Royal College of Obstetricians and Gynaecologists. Thrombosis and Embolism during Pregnancy and the Puerperium, Reducing the Risk. Green-Top Guideline No. 37a. 2015
  • 15 Palmerola KL, D'Alton ME, Brock CO, Friedman AM. A comparison of recommendations for pharmacologic thromboembolism prophylaxis after caesarean delivery from three major guidelines. BJOG 2016; 123 (13) 2157-2162
  • 16 D'Alton ME, Ananth CV. , eds. New York's Safe Motherhood Initiative: A Collaborative Effort. Semin Perinatol 2016; 40 (02) 79-136
  • 17 Bates SM, Greer IA, Pabinger I, Sofaer S, Hirsh J. Venous thromboembolism, thrombophilia, antithrombotic therapy, and pregnancy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 2008; 133 (6, Suppl): 844S-886S
  • 18 Jacobsen AF, Skjeldestad FE, Sandset PM. Incidence and risk patterns of venous thromboembolism in pregnancy and puerperium--a register-based case-control study. Am J Obstet Gynecol 2008; 198 (02) 233.e1-233.e7
  • 19 Friedman AM, D'Alton ME. Venous thromboembolism bundle: Risk assessment and prophylaxis for obstetric patients. Semin Perinatol 2016; 40 (02) 87-92
  • 20 New York State Department of Health website. Available at: https://profiles.health.ny.gov/hospital/designated_center/Level+1+Perinatal+Center . Accessed November 3, 2016
  • 21 Main EK, Goffman D, Scavone BM. , et al; National Partnership for Maternal Safety; Council on Patient Safety in Women's Health Care. National Partnership for Maternal Safety: Consensus Bundle on Obstetric Hemorrhage. Obstet Gynecol 2015; 126 (01) 155-162
  • 22 Hehir MP, Ananth CV, Wright JD, Siddiq Z, D'Alton ME, Friedman AM. Severe maternal morbidity and comorbid risk in hospitals performing <1000 deliveries per year. Am J Obstet Gynecol 2017; 216 (02) 179.e1-179.e12